drugset / Trial / NCT01479192
Fenretinide in Healthy Young Women at Genetic and Familial Risk
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this trial is to assess the effect of fenretinide (4-HPR), a vitamin A derivative, in reducing the incidence of breast cancer in healthy premenopausal women at increased familial/genetic risk for breast cancer
Timeline
- Start
- 2009-12
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fenretinide | Small molecule | 100 mg | — |